Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery

National Medical Journal of China

Volumn 88, Issue 21, 2008, Pages 1476-1480

  Yang, Xue Yuan ^a   Wu, Xin Min ^a   Wang, Shi ^a   Wang, Qi ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Betaloc; Coronary disease; Myocardial infarction; Surgery procedures, operative

Indexed keywords

CREATINE KINASE; METOPROLOL;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; UNSTABLE ANGINA PECTORIS;

AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; METOPROLOL; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SYMPATHOLYTICS; TREATMENT OUTCOME;

EID: 50249124432     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Akavipat P, Ittichaikulthol W, Tuchinda L, et al. The Thai Anesthesia Incidents (THAI Study) of anesthetic risk factors related to perioperative death and perioperative cardiovascular complications in intracranial surgery. J Med Assoc Thai, 2007, 90:1565-1572.
2. Lindenauer PK, Fitzgerald J, Hoople N, et al. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med, 2004, 164:762-766.
3. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med, 1996, 335:1713-1720.
4. Poldermans D, Boersma E, Bax JJ, et al. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group: the effect of bisoprolol on perioporative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med, 1999, 341: 1789-1794.
5. Auerbach A, Goldman L Assessing and reducing the cardiac risk of noncardiac surgery. Circulation, 2006, 113:1361-1376.
6. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology, 1998, 88: 7-17.
7. McSPI Europe Research Group. Perioperative sympatholysis. Anesthesiology, 1997, 86:346-363.
8. Stevens RD, Burri H, Trainer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg, 2003, 97:623-633.
9. Cruickshank JM. Beta-blockers and diabetes: the bad guys come good. Cardiovasc Drugs Ther, 2002, 16:457-470.
10. Karapandzic VM, Vujisic-Tesic BD, Colovic RB, et al. Coronary artery revascularization prior to abdo minal nonvascular surgery. Cardiovasc Revasc Med, 2008, 9:18-23.
11. Daumerie G, Fleisher LA. Perioperative beta-blocker and statin therapy. Curr Opin Anaesthesiol, 2008, 21:60-65.